These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19068274)

  • 1. Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findings.
    Mandalà M; Barni S; Floriani I; Isa L; Fornarini G; Marangolo M; Mosconi S; Corsi D; Rulli E; Frontini L; Cortesi E; Zaniboni A; Aglietta M; Labianca R
    Eur J Cancer; 2009 Jan; 45(1):65-73. PubMed ID: 19068274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of irinotecan plus infusional fluorouracil/l-leucovorin (FOLFIRI) in patients with fluoropyrimidine-resistant metastatic colorectal cancer].
    Moriwaki T; Hyodo I; Nishina T; Kajiwara T; Kataoka J; Hori S; Nasu J; Imamine S; Iguchi H
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2249-53. PubMed ID: 18079624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Khorana AA; Francis CW; Culakova E; Lyman GH
    Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
    Matsumoto S; Nishimura T; Kanai M; Mori Y; Nagayama S; Kawamura J; Nomura A; Miyamoto S; Kitano T; Ishiguro H; Yanagihara K; Teramukai S; Sakai Y; Chiba T; Fukushima M
    Chemotherapy; 2008; 54(5):395-403. PubMed ID: 18781065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
    Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S
    J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
    Otten HM; Mathijssen J; ten Cate H; Soesan M; Inghels M; Richel DJ; Prins MH
    Arch Intern Med; 2004 Jan; 164(2):190-4. PubMed ID: 14744843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in colorectal cancer patients with central venous catheters for 5-FU infusion-based pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Yanagi H; Noda M; Ikeuchi H; Nakano H; Gega M; Tsukamoto K; Oshima T; Inoue T; Fujiwara Y; Shoji Y; Sakaki T; Higasa S; Hashimoto-Tamaoki T; Yamamura T
    Oncol Rep; 2005 Apr; 13(4):627-32. PubMed ID: 15756434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.
    Wolff K; Wein A; Reulbach U; Männlein G; Brückl V; Meier C; Ostermeier N; Schwab SA; Horbach T; Hohenberger W; Hahn EG; Boxberger F
    Anticancer Drugs; 2009 Mar; 20(3):165-73. PubMed ID: 19125117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
    Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
    Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
    Chew HK; Wun T; Harvey DJ; Zhou H; White RH
    J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
    Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
    Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience.
    Nobili E; Di Cicilia R; Di Battista M; Morselli-Labate AM; Paragona M; Corbelli J; Macchini M; Prandoni P; Biasco G; Brandi G
    Pathophysiol Haemost Thromb; 2010; 37(1):30-4. PubMed ID: 20956868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy with 5-fluorouracil in a patient with colorectal cancer and Familial Mediterranean Fever.
    Purim O; Sulkes A; Brenner B
    Anticancer Drugs; 2007 Jul; 18(6):733-5. PubMed ID: 17762405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
    Khorana AA; Francis CW; Culakova E; Kuderer NM; Lyman GH
    Cancer; 2007 Nov; 110(10):2339-46. PubMed ID: 17918266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.